Inactive Instrument

Analyst Reco. Tivity Health, Inc.

Equities

TVTY

US88870R1023

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Barrington Research Downgrades Tivity Health to Market Perform From Outperform on Stone Point Capital Acquisition	22-04-05	MT
Credit Suisse Raises Tivity Health's Price Target to $31 from $29 After In Line Q4 Results, Higher-than-Expected 2022 Outlook; Keeps Neutral Rating	22-03-11	MT
Barrington Research Lifts Tivity Health's Price Target to $35 From $33, Maintains Outperform Rating	22-02-25	MT
Credit Suisse Upgrades Tivity Health to Neutral from Underperform, Raises PT to $29 from $25; Says Digital Health Investments, Interest Likely to Remain Hot	22-01-07	MT
Today on Wall Street: Is it legit?	22-01-07
ANALYST RECOMMANDATIONS : AT&T, BP Plc, Costco, Lyft, Starbucks...	22-01-07
Credit Suisse Adjusts Tivity Health's Price Target to $25 from $21, Keeps Underperform Rating	21-11-09	MT
Barrington Adjusts PT on Tivity Health to $33 From $31 After Q3 Earnings Beat, 2021 Guidance Increase, Maintains Outperform	21-11-03	MT
Piper Sandler Adjusts Tivity Health's Price Target to $27 From $25, Maintains Neutral Rating	21-11-03	MT
TIVITY HEALTH : Truist Securities Adjusts Tivity Health's Price Target to $25 From $28, Reiterates Hold Rating	21-08-23	MT
TIVITY HEALTH : Cantor Fitzgerald Adjusts Tivity Health's Price Target to $33 From $36, Maintains Overweight Rating	21-08-05	MT
TIVITY HEALTH : Piper Sandler Adjusts Tivity Health's Price Target to $25 From $27, Maintains Neutral Rating	21-08-05	MT
TIVITY HEALTH : Cantor Fitzgerald Adjusts Tivity Health's Price Target to $36 From $32, Reiterates Overweight Rating	21-06-09	MT
TIVITY HEALTH : Barrington Research Adjusts Price Target on Tivity Health to $32 From $28, Maintains Outperform Rating	21-02-25	MT
TIVITY HEALTH : Credit Suisse Downgrades Tivity Health to Underperform from Neutral, Keeps $19 Price Target	21-01-15	MT
TIVITY HEALTH : Truist Adjusts Tivity Health's Price Target to $22 From $18, Reiterates Hold Rating	21-01-05	MT
TIVITY HEALTH : Credit Suisse Adjusts Tivity Health's Price Target to $19 From $16, Maintains Neutral Rating	20-12-18	MT
Tivity Health : S&P Upgrades Tivity Health Rating One Notch To 'B+' Following NutriSystem Divestiture, Outlook Positive; First-Lien Rating Raised	20-12-16	MT
TIVITY HEALTH : Guggenheim Upgrades Tivity Health to Buy from Neutral, Sets $21 Price Target	20-11-23	MT
TIVITY HEALTH : Cantor Fitzgerald Upgrades Tivity Health to Overweight From Neutral, $25 Price Target	20-11-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Tivity Health, Inc.

Equities

TVTY

US88870R1023

Analyst Reco.

Filters